Every SEC Form 3/4/5 on record for this filer (CIK 1689325) — 2 issuers, 25 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ANIP | ANI PHARMACEUTICALS INC | Director | 2020-08-07 → 2026-06-10 | 13 | −$2M |
| ENDP | Endo International plc | President, Par Pharmaceutical · lapsed | 2016-11-08 → 2019-04-04 | 14 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ANIP | 2025-09-03 | Sell | 7,292 | $94.94 | $692,302 | 22,660 |
| ANIP | 2025-08-20 | Sell | 5,421 | $89.73 | $486,426 | 29,952 |
| ANIP | 2024-03-04 | Sell | 7,000 | $65.20 | $456,400 | 26,627 |
| ANIP | 2023-08-14 | Sell | 3,000 | $60.37 | $181,110 | 33,627 |
| ANIP | 2021-12-07 | Buy | 3,000 | $42.26 | $126,780 | 19,713 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.